A Phase I/II Randomized Trial of the Safety and Immunogenicity of Cold Adapted Influenza Vaccine (FluMist) in HIV-Infected Children and Adolescents.
Latest Information Update: 02 Nov 2021
Price :
$35 *
At a glance
- Drugs Influenza virus vaccine live (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 25 Jun 2010 Results reported in the Journal of Acquired Immune Deficiency Syndromes.
- 05 Aug 2008 Results reported in Vaccine journal.
- 11 Nov 2005 New trial record.